a month ago
MNPR
AnalystsJeet MukherjeeJeet Mukherjee's Stock Forecasts
AnalystsJeet Mukherjee
Sectors:
Industries:
Analyst Ranking
Top 7%
#369 out of 5336 analysts
Average Return
+30.35%
Win Rate
73%43 out of 59
Risk vs Reward
Poor
Good
Jeet Mukherjee's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Faeth Therapeutics IncFTH | +170.99% | $10.79 | $29.24 | 2026-06-11 - 2026-07-27 | Strong Buy |
Monopar TherapeuticsMNPR | +145.56% | $44.93 | $110.33 | 2025-09-09 - 2026-07-27 | Strong Buy |
Nurix Therapeutics IncNRIX | +125.29% | $10.40 | $23.43 | 2025-10-23 - 2026-07-27 | Strong Buy |
Faeth Therapeutics IncFTH | +111.12% | $13.85 | $29.24 | 2026-06-15 - 2026-07-27 | Strong Buy |
Monopar TherapeuticsMNPR | +102.48% | $54.49 | $110.33 | 2025-09-15 - 2026-07-27 | Strong Buy |
Jeet Mukherjee Analyst Color
Get additional color on Jeet Mukherjee's coverage of popular stocks
3 months ago
ARVN
5 months ago
PVLA
8 months ago
NRIX
8 months ago
KYMR
Jeet Mukherjee's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Faeth Therapeutics IncFTH | 3 | Strong Buy | $55.00 | +88.10% | Reiterates | 12 days ago |
Nurix Therapeutics IncNRIX | 8 | Strong Buy | $32.00 | +36.58% | Reiterates | 18 days ago |
Verastem IncVSTM | 7 | Strong Buy | $18.00 | +196.05% | Maintains | a month ago |
Monopar TherapeuticsMNPR | 7 | Strong Buy | $117.00 | +6.05% | Maintains | a month ago |
Kymera Therapeutics IncKYMR | 7 | Strong Buy | $134.00 | +21.76% | Reiterates | a month ago |
Ascentage Pharma Group InternationalAAPG | 3 | Strong Buy | $48.00 | +154.10% | Reiterates | a month ago |
Immunitybio IncIBRX | 2 | Strong Buy | $12.00 | +71.67% | Reiterates | 2 months ago |
Arvinas IncARVN | 4 | Strong Buy | $18.00 | +118.98% | Maintains | 3 months ago |
Viking Therapeutics IncVKTX | 1 | Strong Buy | $125.00 | +258.47% | Reiterates | 3 months ago |
Aardvark Therapeutics IncAARD | 4 | Strong Buy | $9.00 | +34.53% | Reiterates | 4 months ago |
Perspective Therapeutics IncCATX | 4 | Strong Buy | $14.00 | +396.45% | Reiterates | 4 months ago |
Innate Pharma SaIPHA | 1 | Strong Buy | $8.00 | +351.47% | Assumes | 5 months ago |
Arrivent Biopharma IncAVBP | 1 | Strong Buy | $42.00 | +39.26% | Assumes | 5 months ago |
Palvella Therapeutics IncPVLA | 5 | Strong Buy | $215.00 | +51.65% | Maintains | 5 months ago |
Bicara Therapeutics IncBCAX | 1 | Strong Buy | $28.00 | +0.68% | Initiates Coverage On | 7 months ago |
Foghorn Therapeutics IncFHTX | 1 | Strong Buy | $11.00 | +111.54% | Initiates Coverage On | 7 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.